Market cap of Organogenesis Holdings Inc [ORGO] reaches 574.53M – now what?

MU Stock

Organogenesis Holdings Inc [NASDAQ: ORGO] traded at a high on Thursday, posting a 1.80 gain after which it closed the day’ session at $4.53.

The results of the trading session contributed to over 3874018 shares changing hands. Over the past one week, the price volatility of Organogenesis Holdings Inc stands at 5.27% while the volatility over the past one month is 8.11%.

The market cap for ORGO stock reached $574.53 million, with 125.73 million shares outstanding and 64.38 million shares in the current float. Compared to the average trading volume of 2.01M shares, ORGO reached a trading volume of 3874018 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Organogenesis Holdings Inc [ORGO]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ORGO shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ORGO stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Lake Street have made an estimate for Organogenesis Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 28, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on February 07, 2024, representing the official price target for Organogenesis Holdings Inc stock. Previously, the target price had yet another raise to $5, while Morgan Stanley analysts kept a Equal-Weight rating on ORGO stock.

The Average True Range (ATR) for Organogenesis Holdings Inc is set at 0.34, with the Price to Sales ratio for ORGO stock in the period of the last 12 months amounting to 1.19. The Price to Book ratio for the last quarter was 2.17, with the Price to Cash per share for the same quarter was set at 1.07. Price to Free Cash Flow for ORGO in the course of the last twelve months was 137.45 with Quick ratio for the last quarter at 3.35.

How has ORGO stock performed recently?

Organogenesis Holdings Inc [ORGO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.59. With this latest performance, ORGO shares dropped by -13.22% in over the last four-week period, additionally plugging by 45.66% over the last 6 months – not to mention a rise of 52.53% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ORGO stock in for the last two-week period is set at 54.21, with the RSI for the last a single of trading hit 59.24, and the three-weeks RSI is set at 52.90 for Organogenesis Holdings Inc [ORGO]. The present Moving Average for the last 50 days of trading for this stock 4.43, while it was recorded at 4.35 for the last single week of trading, and 3.47 for the last 200 days.

Organogenesis Holdings Inc [ORGO]: Deeper insight into the fundamentals

Organogenesis Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.35 and a Current Ratio set at 3.69.

Insider trade positions for Organogenesis Holdings Inc [ORGO]

There are presently around $48.13%, or 90.23%% of ORGO stock, in the hands of institutional investors. The top three institutional holders of ORGO stocks are: MORGAN STANLEY with ownership of 11.58 million shares, which is approximately 8.7318%. SOLEUS CAPITAL MANAGEMENT, L.P., holding 11.52 million shares of the stock with an approximate value of $$32.25 million in ORGO stocks shares; and SOLEUS CAPITAL MANAGEMENT, L.P., currently with $$14.24 million in ORGO stock with ownership which is approximately 3.8372%.